About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
17
As Collaborator
0
Total Enrollment
1,363
By Phase
PHASE3: 4PHASE1/PHASE2: 2PHASE2/PHASE3: 1PHASE2: 6PHASE1: 4
By Status
COMPLETED: 7ACTIVE_NOT_RECRUITING: 4RECRUITING: 3NOT_YET_RECRUITING: 3
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
Hover over trial bars to see details
Recent Trials
NCT07087054Lead Sponsor
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
PHASE3Recruiting
141 participants
Started: Oct 31, 2025 · Completed: Jan 31, 2030
NCT07129252Lead Sponsor
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
PHASE1/PHASE2Not yet recruiting
150 participants
Started: Oct 31, 2025 · Completed: Aug 31, 2029
NCT07144163Lead Sponsor
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
PHASE3Not yet recruiting
150 participants
Started: Sep 30, 2025 · Completed: May 31, 2027
NCT07159841Lead Sponsor
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
PHASE2/PHASE3Not yet recruiting
153 participants
Started: Sep 30, 2025 · Completed: Mar 31, 2030
NCT06712823Lead Sponsor
An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894
PHASE2Recruiting
150 participants
Started: Feb 25, 2025 · Completed: Nov 30, 2027
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...